Psychosis during interferon in eosinophilic leukaemia.
Hendrick
A
A
South Tyneside District Hospital, South Shields, Tyne and Wear, UK.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003702:Delusions / Q000139:chemically induced*; D003937:Diagnosis, Differential; D015251:Epirubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D017809:Fatal Outcome; D017619:Hemibody Irradiation; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage; D017681:Hypereosinophilic Syndrome / Q000628:therapy*; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D017254:Leukemic Infiltration / Q000175:diagnosis; D008297:Male; D010166:Palliative Care; D011537:Pruritus / Q000175:diagnosis / Q000523:psychology; D012867:Skin / Q000473:pathology; D013001:Somatoform Disorders / Q000175:diagnosis / Q000523:psychology; D013156:Splenectomy; D014657:Vasculitis / Q000175:diagnosis; D014750:Vincristine / Q000008:administration & dosage
D000305:Adrenal Cortex Hormones; D007155:Immunologic Factors; D016898:Interferon-alpha; D003561:Cytarabine; D015251:Epirubicin; D014750:Vincristine; D005047:Etoposide; D003520:Cyclophosphamide; D006918:Hydroxyurea